No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
AbbVie Launches Skyrizi® (Risankizumab) in Canada for UC
On 4 March 2025, AbbVie announced that Skyrizi® (risankizumab) is now available in Canada for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had…